acyclovir
Generic: acyclovir
Labeler: actavis pharma, inc.Drug Facts
Product Profile
Brand Name
acyclovir
Generic Name
acyclovir
Labeler
actavis pharma, inc.
Dosage Form
OINTMENT
Routes
Active Ingredients
acyclovir 50 mg/g
Manufacturer
Identifiers & Regulatory
Product NDC
0591-1159
Product ID
0591-1159_9a0c599a-742a-48f5-ae69-cd9e8cbaa604
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA AUTHORIZED GENERIC
Application Number
NDA018604
Listing Expiration
2026-12-31
Marketing Start
2014-04-11
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
05911159
Hyphenated Format
0591-1159
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
acyclovir (source: ndc)
Generic Name
acyclovir (source: ndc)
Application Number
NDA018604 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 50 mg/g
Packaging
- 1 TUBE in 1 CARTON (0591-1159-30) / 30 g in 1 TUBE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["TOPICAL"], "spl_id": "9a0c599a-742a-48f5-ae69-cd9e8cbaa604", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "unii": ["X4HES1O11F"], "rxcui": ["197312"], "spl_set_id": ["b360a808-a24d-4f3c-89a7-9941422d17d6"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["ACTAVIS PHARMA, INC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 TUBE in 1 CARTON (0591-1159-30) / 30 g in 1 TUBE", "package_ndc": "0591-1159-30", "marketing_start_date": "20140411"}], "brand_name": "Acyclovir", "product_id": "0591-1159_9a0c599a-742a-48f5-ae69-cd9e8cbaa604", "dosage_form": "OINTMENT", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "0591-1159", "generic_name": "acyclovir", "labeler_name": "ACTAVIS PHARMA, INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "50 mg/g"}], "application_number": "NDA018604", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20140411", "listing_expiration_date": "20261231"}